CFGS
BMY icon

Concourse Financial Group Securities’s Bristol-Myers Squibb BMY Stock Holding History

Concourse Financial Group Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,851
Closed -$799K – 244
2024
Q4 		$799K Buy
13,851
+1,118
+9% +$62.5K 0.05% 371
2024
Q3 		$659K Buy
12,733
+255
+2% +$12K 0.04% 397
2024
Q2 		$518K Sell
12,478
-905
-7% -$40.5K 0.03% 437
2024
Q1 		$726K Sell
13,383
-846
-6% -$43.1K 0.05% 367
2023
Q4 		$730K Sell
14,229
-27,326
-66% -$1.43M 0.05% 359
2023
Q3 		$2.41M Sell
41,555
-5,659
-12% -$347K 0.19% 119
2023
Q2 		$3.02M Buy
47,214
+236
+0.5% +$15.8K 0.23% 98
2023
Q1 		$3.26M Buy
46,978
+1,902
+4% +$134K 0.25% 91
2022
Q4 		$3.24M Buy
45,076
+1,523
+3% +$115K 0.26% 89
2022
Q3 		$3.1M Buy
43,553
+3,631
+9% +$263K 0.29% 84
2022
Q2 		$3.1M Sell
39,922
-1,559
-4% -$119K 0.26% 87
2022
Q1 		$3.05M Sell
41,481
-8,658
-17% -$581K 0.22% 99
2021
Q4 		$3.13M Sell
50,139
-6,848
-12% -$402K 0.18% 117
2021
Q3 		$3.4M Sell
56,987
-934
-2% -$61.5K 0.21% 106
2021
Q2 		$3.87M Buy
57,921
+1,892
+3% +$123K 0.24% 90
2021
Q1 		$3.56M Buy
56,029
+2,341
+4% +$146K 0.25% 86
2020
Q4 		$3.36M Buy
53,688
+3,140
+6% +$193K 0.25% 86
2020
Q3 		$3.05M Buy
50,548
+1,268
+3% +$76.3K 0.27% 83
2020
Q2 		$2.9M Buy
49,280
+1,941
+4% +$116K 0.28% 79
2020
Q1 		$2.64M Buy
47,339
+2,078
+5% +$127K 0.29% 71
2019
Q4 		$2.9M Buy
45,261
+31,934
+240% +$1.83M 0.29% 75
2019
Q3 		$676K Sell
13,327
-32,830
-71% -$1.54M 0.17% 103
2019
Q2 		$2.09M Buy
46,157
+22,343
+94% +$1.04M 0.21% 90
2019
Q1 		$1.14M Sell
23,814
-325
-1% -$16.2K 0.12% 148
2018
Q4 		$1.25M Buy
24,139
+13,430
+125% +$722K 0.15% 130
2018
Q3 		$665K Buy
+10,709
New +$636K 0.19% 118

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Concourse Financial Group Securities's BMY Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 13,851 shares — an estimated $799K sold.

Concourse Financial Group Securities first reported a position in BMY in Q3 2018 and held it in 26 quarters. The position peaked at $3.87M in Q2 2021. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 13,851 Bristol-Myers Squibb shares in Q1 2025, an estimated $799K.
  • Concourse Financial Group Securities first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Bristol-Myers Squibb position peaked at $3.87M in Q2 2021.
  • 2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.